“…Several imaging modalities are available in detection and localization of NPTs, including octreotide scintigraphy or SRS (7,13,19,27,38) using radiolabeled octreotide, 111 In-DTPA-D-Phe octreotide, which binds with high affinity to somatostatin receptors (sst), transabdominal ultrasound (US), EUS (1,3,4,9,12,13,25,28,(36)(37)(38), CT (1-4, 6-9, 11, 13, 15, 16, 24, 25, 27, 31, 33, 35-38), and magnetic resonance imaging (MRI) (2,5,20,23,24,(29)(30)(31)34 In some cases, stimulated arteriography and percutaneous transhepatic venous sampling is still necessary when no other imaging study can locate a hormone-secreting tumor, but these methods are invasive (17,22).…”